ログイン

Nuclear magnetic resonance

Nuclear magnetic resonance
64問 • 1年前
  • Quinn Karylle Fuentes
  • 通報

    問題一覧

  • 1

    transitions between energy levels may be generated by radiant energy if the molecules are first placed in a magnetic field.

    Nuclear magnetic resonance

  • 2

    investigate the properties of organic molecules, like sructure/ identity, and molecular configuration

    Nuclear magnetic resonance

  • 3

    an energy transfer is possible between the base energy to a higher energy leve

    Nuclear magnetic resonance

  • 4

    energy transfer takes place at a wavelength that corresponds to radio frequencies

    Nuclear magnetic resonance

  • 5

    The signal that matches this transfer is measured in many ways and processed in order to yield an NMR spectrum for the nucleus concerned. (T/F)

    True

  • 6

    the plot of radio frequency applied against absorption

    NMR Spectrum

  • 7

    signal in the spectrum

    Resonance

  • 8

    form of electromagnetic radiation to pump the excess alpha oriented nuclei into the beta state.

    Nuclear magnetic resonance

  • 9

    exploits the magnetic properties of certain atomic nuclei. ... Thus, in organic chemistry practice, NMR analysis is used to confirm the identity of a substance. (T/F)

    True

  • 10

    frequency of the signal expressed with reference to a standard Computed as the difference between the resonance frequency of the nucleus and a standard, relative to the standard.

    Chemical shift

  • 11

    as a fraction of the nominal resonance frequency or parts-per-million (ppm) are used.

    Chemical shift

  • 12

    a phenomenon that takes place due to the neighboring proton

    Spin-spin couple

  • 13

    peaks are split into multiplets which depend upon the groups on adjacent nuclei.

    Spin spin coupling

  • 14

    difference between the adjacent sub-peaks in a split signal

    J coupling

  • 15

    The basic instrumentation needed to measure NMR spectra includes (

    magnet with strong, stable homogenous field, radio receiver and detector, radiofrequency transmitter:, coil of wire, cell containing the sample

  • 16

    It is an instrumental method for identifying the chemical constitution of a substance by means of the separation of gaseous ions according to their differing mass and charge.

    Mass spectrometry.

  • 17

    generates multiple ions from the sample under investigation, it then separates them according to their specific mass-to-charge ratio (m/z), and then records the relative abundance of each ion type.

    Mass spectrometry

  • 18

    For producing gaseousionsfrom the substance being studied

    Ion source

  • 19

    For resolving the ionsinto their characteristicsmass components according to their mass-to-charge ratio.

    Analyzer

  • 20

    For detecting the ions and recording the relative abundance of each of the resolved ionic species.

    Detectors systems

  • 21

    Mass spectrometer always work with positive ions (T/F)

    True

  • 22

    The ions are then deflected by a magnetic field according to their masses. The lighter they are, the more they are deflected

    Deflected.

  • 23

    The ions are accelerated so that they all have the same kinetic energy

    Accelerated.

  • 24

    is a process in which a solution of mixture containing inert materials, drug principles and impurities is separated into its components while moving through a bed of fixed porous solid having different and reversible affinities for the substance being separate

    Chromatography

  • 25

    a fixed bed core of large surface area.

    Stationary phase

  • 26

    a fluid which moves through or over the surface of the stationary phase.

    Mobile phase

  • 27

    Whar are the 2 types of chromatography

    Stationary phase, Mobile phase

  • 28

    It brings about the separation of a mixture through a competitive process in which the molecules of the mobile phase compete with the analyte molecules for polar adsorption site on the adsorbent.

    Adsorption Chromatography

  • 29

    The chromatographic process is known as where the mobile phase is liquid.

    liquid-solid chromatography

  • 30

    The chromatographic process is known as when the mobile phase is a gas

    gas – solid chromatography

  • 31

    Chromatographic technique in which the mobile and stationary phases are liquids referred to as liquid-liquid chromatography (LLC)

    Partition Chromatography

  • 32

    Separation in partition elution chromatography is based upon

    Nernst’s law.

  • 33

    According to this law, when two practically immiscible solvents are in contact with each other and substance which is soluble in each is added, the substance distributes itself in such a way that at equilibrium and at a given temperature the ratio of the concentrations of the two solutions is constant.

    Nernst’s law.

  • 34

    it is the activity ratio rather than the concentration ratio which remains constant

    Nernst’s law.

  • 35

    the ratio of the distance travelled over the paper sheets by a given compound to the distance travelled by the front of the mobile phase, from the point of application of the test substances.

    Retardation Factor (Rf)

  • 36

    the ratio between the distances travelled by a given compound and a reference substance.

    Retardation Reference (Rr)

  • 37

    The materials used to pack column for use inion-exchange chromatography are either cationic or anionic exchange resins.

    Ion-Exchange Chromatography

  • 38

    These substances are insoluble in water and as the name implies, exchange cations or anions in solution in the mobile phase which come in contact with the active sites of exchange resins

    Ion-Exchange Chromatography

  • 39

    Contains either sulfonic acid (-SO3H) or carboxylic acid

    Cationic exchangers

  • 40

    Resin contain either quaternary ammonium or amino functional group in the Y position.

    Anionic exchange

  • 41

    stationary phase consists of a polymeric matrix onto the surface of which ionic functional groups, e.g. carboxylic acid or quaternary amines have been chemically bonded

    Ion exchange chromatography

  • 42

    As the mobile phase passes over this surface, ionic solutes are retained by forming electrostatic chemical bonds with the functional groups. The mobile phase used in ion exchange chromatography are always liquid.

    Ion exchange chromatography

  • 43

    This is also known as gel filtration or gel permeation chromatography, and maybe defined as a separation procedure in which differential migration of solute molecules is based on molecular size

    Molecular Exclusion Chromatography

  • 44

    Column material consists of a network-like structure of polymer material having pores of various sizes which exclude some molecules but permit the passage of other smaller molecules.

    Molecular Exclusion Chromatography

  • 45

    The simplest type of chromatographic column consists of a separation flask and a cylindrical glass tube constricted at one end.

    Column chromatography

  • 46

    The material placed in the column to absorb the drug is referred to as the .

    Adsorbent

  • 47

    Purified siliceous earth, activated alumina, silica gel and calcium carbonate are examples of adsorbents commonly used. (T/F)

    True

  • 48

    The adsorbent is uniformly and firmly packed into the tube so that the solvent called will pass through it.

    Mobile phase

  • 49

    The column adsorbent is treated with fresh portions of solvent referred to as ________ to bring about the separation of the components as each drug progress down the column at a characteristic rate in a chromatogram.

    Developer

  • 50

    used in highpressure liquid chromatography and gas chromatography

    Column chromatography

  • 51

    Ether is used as

    Eluant

  • 52

    When the separated compounds are colored or fluoresce under UV light the adsorbent column is forced, intact from the tube and the fractions are easily divided into segments with a knife.

    Column Chromatography

  • 53

    When the compounds are radioactive, their position on the column may be determined by the use of a

    Geiger-Muller counter.

  • 54

    Another procedure commonly used to develop chromatogram is known as

    Elution chromatography

  • 55

    The column is washed with suitable solvent referred to as

    eluants

  • 56

    until each compound is successively obtained in the effluent liquid known as the

    Eluate

  • 57

    The basic principle of separation in the partition chromatography is that of difference in partition coefficients of substances between two immiscible liquids.

    Paper-Partition Chromatography

  • 58

    One of which is a stationary phase supported on a solid adsorbent with the other mobile liquid phase flowing through it.

    Paper-Partition Chromatography

  • 59

    which is accomplished by allowing the mobile phase to flow downward on the paper strip.

    Descending Chromatography

  • 60

    An which the mobile phase is allowed to rise upward on the paper by capillary attraction

    Ascending Chromatography

  • 61

    in which the mobile phase moves out in concentric circles from the center of a circular piece of paper.

    Radial Chromatography,

  • 62

    When the compounds are colorless they may be visualized painting or spraying the extruded column with a

    color-forming agent.

  • 63

    It involves the spotting of a sampler of a mixture of components at one end of an adsorbent-coated glass plate or other suitable support followed by passage of solvent through the adsorbent for the purpose of separating components of the sample

    Thin-Layer Chromatography

  • 64

    are the most widely used adsorbents

    Silica Gel G, Alumina

  • Cell structure.

    Cell structure.

    Quinn Karylle Fuentes · 28問 · 2年前

    Cell structure.

    Cell structure.

    28問 • 2年前
    Quinn Karylle Fuentes

    Electrolytes and non electrolytes

    Electrolytes and non electrolytes

    Quinn Karylle Fuentes · 29問 · 2年前

    Electrolytes and non electrolytes

    Electrolytes and non electrolytes

    29問 • 2年前
    Quinn Karylle Fuentes

    MW

    MW

    Quinn Karylle Fuentes · 45問 · 2年前

    MW

    MW

    45問 • 2年前
    Quinn Karylle Fuentes

    POST LAB (EXP 4)

    POST LAB (EXP 4)

    Quinn Karylle Fuentes · 38問 · 2年前

    POST LAB (EXP 4)

    POST LAB (EXP 4)

    38問 • 2年前
    Quinn Karylle Fuentes

    Density and specific gravity

    Density and specific gravity

    Quinn Karylle Fuentes · 34問 · 2年前

    Density and specific gravity

    Density and specific gravity

    34問 • 2年前
    Quinn Karylle Fuentes

    FORCES OF ATTRACTION

    FORCES OF ATTRACTION

    Quinn Karylle Fuentes · 18問 · 2年前

    FORCES OF ATTRACTION

    FORCES OF ATTRACTION

    18問 • 2年前
    Quinn Karylle Fuentes

    Microbial growth

    Microbial growth

    Quinn Karylle Fuentes · 63問 · 2年前

    Microbial growth

    Microbial growth

    63問 • 2年前
    Quinn Karylle Fuentes

    Introduction.

    Introduction.

    Quinn Karylle Fuentes · 61問 · 2年前

    Introduction.

    Introduction.

    61問 • 2年前
    Quinn Karylle Fuentes

    Microbial control.

    Microbial control.

    Quinn Karylle Fuentes · 97問 · 2年前

    Microbial control.

    Microbial control.

    97問 • 2年前
    Quinn Karylle Fuentes

    States of matter

    States of matter

    Quinn Karylle Fuentes · 100問 · 2年前

    States of matter

    States of matter

    100問 • 2年前
    Quinn Karylle Fuentes

    Introduction.

    Introduction.

    Quinn Karylle Fuentes · 86問 · 2年前

    Introduction.

    Introduction.

    86問 • 2年前
    Quinn Karylle Fuentes

    Drug development.

    Drug development.

    Quinn Karylle Fuentes · 77問 · 2年前

    Drug development.

    Drug development.

    77問 • 2年前
    Quinn Karylle Fuentes

    CGMP

    CGMP

    Quinn Karylle Fuentes · 9問 · 2年前

    CGMP

    CGMP

    9問 • 2年前
    Quinn Karylle Fuentes

    Pharmaceutical ingredients.

    Pharmaceutical ingredients.

    Quinn Karylle Fuentes · 24問 · 2年前

    Pharmaceutical ingredients.

    Pharmaceutical ingredients.

    24問 • 2年前
    Quinn Karylle Fuentes

    Powdered & granules

    Powdered & granules

    Quinn Karylle Fuentes · 43問 · 2年前

    Powdered & granules

    Powdered & granules

    43問 • 2年前
    Quinn Karylle Fuentes

    Capsule.

    Capsule.

    Quinn Karylle Fuentes · 24問 · 2年前

    Capsule.

    Capsule.

    24問 • 2年前
    Quinn Karylle Fuentes

    Tablets.

    Tablets.

    Quinn Karylle Fuentes · 23問 · 2年前

    Tablets.

    Tablets.

    23問 • 2年前
    Quinn Karylle Fuentes

    Calculatiom of dose

    Calculatiom of dose

    Quinn Karylle Fuentes · 3回閲覧 · 66問 · 2年前

    Calculatiom of dose

    Calculatiom of dose

    3回閲覧 • 66問 • 2年前
    Quinn Karylle Fuentes

    Postlab 5&6

    Postlab 5&6

    Quinn Karylle Fuentes · 29問 · 2年前

    Postlab 5&6

    Postlab 5&6

    29問 • 2年前
    Quinn Karylle Fuentes

    COLLIGATIVE PROPERTIES.

    COLLIGATIVE PROPERTIES.

    Quinn Karylle Fuentes · 33問 · 2年前

    COLLIGATIVE PROPERTIES.

    COLLIGATIVE PROPERTIES.

    33問 • 2年前
    Quinn Karylle Fuentes

    SEMI SOLID

    SEMI SOLID

    Quinn Karylle Fuentes · 69問 · 2年前

    SEMI SOLID

    SEMI SOLID

    69問 • 2年前
    Quinn Karylle Fuentes

    Basic immunology

    Basic immunology

    Quinn Karylle Fuentes · 60問 · 2年前

    Basic immunology

    Basic immunology

    60問 • 2年前
    Quinn Karylle Fuentes

    Basic immunology (2)

    Basic immunology (2)

    Quinn Karylle Fuentes · 62問 · 2年前

    Basic immunology (2)

    Basic immunology (2)

    62問 • 2年前
    Quinn Karylle Fuentes

    Transdermal

    Transdermal

    Quinn Karylle Fuentes · 44問 · 2年前

    Transdermal

    Transdermal

    44問 • 2年前
    Quinn Karylle Fuentes

    Distribution.

    Distribution.

    Quinn Karylle Fuentes · 43問 · 2年前

    Distribution.

    Distribution.

    43問 • 2年前
    Quinn Karylle Fuentes

    Infectious disease.

    Infectious disease.

    Quinn Karylle Fuentes · 65問 · 2年前

    Infectious disease.

    Infectious disease.

    65問 • 2年前
    Quinn Karylle Fuentes

    Infectious diseases (2)

    Infectious diseases (2)

    Quinn Karylle Fuentes · 79問 · 2年前

    Infectious diseases (2)

    Infectious diseases (2)

    79問 • 2年前
    Quinn Karylle Fuentes

    Gram positive ( Bacteriology)

    Gram positive ( Bacteriology)

    Quinn Karylle Fuentes · 35問 · 2年前

    Gram positive ( Bacteriology)

    Gram positive ( Bacteriology)

    35問 • 2年前
    Quinn Karylle Fuentes

    All topic. ( Compressed.)

    All topic. ( Compressed.)

    Quinn Karylle Fuentes · 35問 · 2年前

    All topic. ( Compressed.)

    All topic. ( Compressed.)

    35問 • 2年前
    Quinn Karylle Fuentes

    All topic ( Compressed)

    All topic ( Compressed)

    Quinn Karylle Fuentes · 30問 · 2年前

    All topic ( Compressed)

    All topic ( Compressed)

    30問 • 2年前
    Quinn Karylle Fuentes

    All topics (compressed)

    All topics (compressed)

    Quinn Karylle Fuentes · 13問 · 2年前

    All topics (compressed)

    All topics (compressed)

    13問 • 2年前
    Quinn Karylle Fuentes

    Exercise 6 ; Isotonic solution.

    Exercise 6 ; Isotonic solution.

    Quinn Karylle Fuentes · 28問 · 2年前

    Exercise 6 ; Isotonic solution.

    Exercise 6 ; Isotonic solution.

    28問 • 2年前
    Quinn Karylle Fuentes

    Exercise 5 : Buffers.

    Exercise 5 : Buffers.

    Quinn Karylle Fuentes · 16問 · 2年前

    Exercise 5 : Buffers.

    Exercise 5 : Buffers.

    16問 • 2年前
    Quinn Karylle Fuentes

    Exercise 7 : Factors affecting solubility.

    Exercise 7 : Factors affecting solubility.

    Quinn Karylle Fuentes · 26問 · 2年前

    Exercise 7 : Factors affecting solubility.

    Exercise 7 : Factors affecting solubility.

    26問 • 2年前
    Quinn Karylle Fuentes

    Experiment 8: Disintegration.

    Experiment 8: Disintegration.

    Quinn Karylle Fuentes · 23問 · 2年前

    Experiment 8: Disintegration.

    Experiment 8: Disintegration.

    23問 • 2年前
    Quinn Karylle Fuentes

    Experiment 9 ; Interfacial phenomenon and surface tension.

    Experiment 9 ; Interfacial phenomenon and surface tension.

    Quinn Karylle Fuentes · 35問 · 2年前

    Experiment 9 ; Interfacial phenomenon and surface tension.

    Experiment 9 ; Interfacial phenomenon and surface tension.

    35問 • 2年前
    Quinn Karylle Fuentes

    EXP 9 : Aromatic ammonia spirit.

    EXP 9 : Aromatic ammonia spirit.

    Quinn Karylle Fuentes · 34問 · 2年前

    EXP 9 : Aromatic ammonia spirit.

    EXP 9 : Aromatic ammonia spirit.

    34問 • 2年前
    Quinn Karylle Fuentes

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    Quinn Karylle Fuentes · 34問 · 2年前

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    34問 • 2年前
    Quinn Karylle Fuentes

    EXP 12: ACACIA MUCILAGE

    EXP 12: ACACIA MUCILAGE

    Quinn Karylle Fuentes · 20問 · 2年前

    EXP 12: ACACIA MUCILAGE

    EXP 12: ACACIA MUCILAGE

    20問 • 2年前
    Quinn Karylle Fuentes

    EXP13&14 : Starch and Barrium sulfate.

    EXP13&14 : Starch and Barrium sulfate.

    Quinn Karylle Fuentes · 33問 · 2年前

    EXP13&14 : Starch and Barrium sulfate.

    EXP13&14 : Starch and Barrium sulfate.

    33問 • 2年前
    Quinn Karylle Fuentes

    EXP 15 : Liquid petroleum emulsion 1.0

    EXP 15 : Liquid petroleum emulsion 1.0

    Quinn Karylle Fuentes · 37問 · 2年前

    EXP 15 : Liquid petroleum emulsion 1.0

    EXP 15 : Liquid petroleum emulsion 1.0

    37問 • 2年前
    Quinn Karylle Fuentes

    EXP 15: Liquid petroleum emulsion 1.1

    EXP 15: Liquid petroleum emulsion 1.1

    Quinn Karylle Fuentes · 23問 · 2年前

    EXP 15: Liquid petroleum emulsion 1.1

    EXP 15: Liquid petroleum emulsion 1.1

    23問 • 2年前
    Quinn Karylle Fuentes

    Enterobacteriaceae

    Enterobacteriaceae

    Quinn Karylle Fuentes · 35問 · 2年前

    Enterobacteriaceae

    Enterobacteriaceae

    35問 • 2年前
    Quinn Karylle Fuentes

    Enterobacteriaceae.

    Enterobacteriaceae.

    Quinn Karylle Fuentes · 28問 · 2年前

    Enterobacteriaceae.

    Enterobacteriaceae.

    28問 • 2年前
    Quinn Karylle Fuentes

    LIQUID DOSAGE FORM 1.0

    LIQUID DOSAGE FORM 1.0

    Quinn Karylle Fuentes · 31問 · 2年前

    LIQUID DOSAGE FORM 1.0

    LIQUID DOSAGE FORM 1.0

    31問 • 2年前
    Quinn Karylle Fuentes

    Liquid dosage form

    Liquid dosage form

    Quinn Karylle Fuentes · 12問 · 2年前

    Liquid dosage form

    Liquid dosage form

    12問 • 2年前
    Quinn Karylle Fuentes

    MICROMERITICS 1.0

    MICROMERITICS 1.0

    Quinn Karylle Fuentes · 44問 · 2年前

    MICROMERITICS 1.0

    MICROMERITICS 1.0

    44問 • 2年前
    Quinn Karylle Fuentes

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    Quinn Karylle Fuentes · 22問 · 2年前

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    22問 • 2年前
    Quinn Karylle Fuentes

    EXP 8 : KIRBY-BAUER TECHNIQUE

    EXP 8 : KIRBY-BAUER TECHNIQUE

    Quinn Karylle Fuentes · 40問 · 2年前

    EXP 8 : KIRBY-BAUER TECHNIQUE

    EXP 8 : KIRBY-BAUER TECHNIQUE

    40問 • 2年前
    Quinn Karylle Fuentes

    EXP 9: STAPHYLOCOCCI

    EXP 9: STAPHYLOCOCCI

    Quinn Karylle Fuentes · 29問 · 2年前

    EXP 9: STAPHYLOCOCCI

    EXP 9: STAPHYLOCOCCI

    29問 • 2年前
    Quinn Karylle Fuentes

    Drug incompatibilities.

    Drug incompatibilities.

    Quinn Karylle Fuentes · 41問 · 2年前

    Drug incompatibilities.

    Drug incompatibilities.

    41問 • 2年前
    Quinn Karylle Fuentes

    Drug compatibilities.

    Drug compatibilities.

    Quinn Karylle Fuentes · 41問 · 2年前

    Drug compatibilities.

    Drug compatibilities.

    41問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    Quinn Karylle Fuentes · 35問 · 2年前

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    35問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    Quinn Karylle Fuentes · 30問 · 2年前

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    30問 • 2年前
    Quinn Karylle Fuentes

    SUSPENSION.

    SUSPENSION.

    Quinn Karylle Fuentes · 45問 · 2年前

    SUSPENSION.

    SUSPENSION.

    45問 • 2年前
    Quinn Karylle Fuentes

    Colloidal.

    Colloidal.

    Quinn Karylle Fuentes · 40問 · 2年前

    Colloidal.

    Colloidal.

    40問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY 4 (Rickettsia)

    BACTERIOLOGY 4 (Rickettsia)

    Quinn Karylle Fuentes · 38問 · 2年前

    BACTERIOLOGY 4 (Rickettsia)

    BACTERIOLOGY 4 (Rickettsia)

    38問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY.

    BACTERIOLOGY.

    Quinn Karylle Fuentes · 44問 · 2年前

    BACTERIOLOGY.

    BACTERIOLOGY.

    44問 • 2年前
    Quinn Karylle Fuentes

    Emulsion.

    Emulsion.

    Quinn Karylle Fuentes · 32問 · 2年前

    Emulsion.

    Emulsion.

    32問 • 2年前
    Quinn Karylle Fuentes

    EMULSION

    EMULSION

    Quinn Karylle Fuentes · 42問 · 2年前

    EMULSION

    EMULSION

    42問 • 2年前
    Quinn Karylle Fuentes

    MEDICAL RELATED PROBLEMS.

    MEDICAL RELATED PROBLEMS.

    Quinn Karylle Fuentes · 36問 · 2年前

    MEDICAL RELATED PROBLEMS.

    MEDICAL RELATED PROBLEMS.

    36問 • 2年前
    Quinn Karylle Fuentes

    MEDICATION RELATED PROBLEMS.

    MEDICATION RELATED PROBLEMS.

    Quinn Karylle Fuentes · 33問 · 2年前

    MEDICATION RELATED PROBLEMS.

    MEDICATION RELATED PROBLEMS.

    33問 • 2年前
    Quinn Karylle Fuentes

    Mycology.

    Mycology.

    Quinn Karylle Fuentes · 30問 · 2年前

    Mycology.

    Mycology.

    30問 • 2年前
    Quinn Karylle Fuentes

    Mycology 2.0

    Mycology 2.0

    Quinn Karylle Fuentes · 34問 · 2年前

    Mycology 2.0

    Mycology 2.0

    34問 • 2年前
    Quinn Karylle Fuentes

    m

    m

    Quinn Karylle Fuentes · 15問 · 2年前

    m

    m

    15問 • 2年前
    Quinn Karylle Fuentes

    ppr

    ppr

    Quinn Karylle Fuentes · 25問 · 2年前

    ppr

    ppr

    25問 • 2年前
    Quinn Karylle Fuentes

    MEDICAL DEVICES.

    MEDICAL DEVICES.

    Quinn Karylle Fuentes · 20問 · 2年前

    MEDICAL DEVICES.

    MEDICAL DEVICES.

    20問 • 2年前
    Quinn Karylle Fuentes

    Pharmacokinetics. (1.0)

    Pharmacokinetics. (1.0)

    Quinn Karylle Fuentes · 86問 · 2年前

    Pharmacokinetics. (1.0)

    Pharmacokinetics. (1.0)

    86問 • 2年前
    Quinn Karylle Fuentes

    Pharmacokinetics (1.1)

    Pharmacokinetics (1.1)

    Quinn Karylle Fuentes · 100問 · 2年前

    Pharmacokinetics (1.1)

    Pharmacokinetics (1.1)

    100問 • 2年前
    Quinn Karylle Fuentes

    Pharmacokinetics (1.2)

    Pharmacokinetics (1.2)

    Quinn Karylle Fuentes · 19問 · 2年前

    Pharmacokinetics (1.2)

    Pharmacokinetics (1.2)

    19問 • 2年前
    Quinn Karylle Fuentes

    Introduction.

    Introduction.

    Quinn Karylle Fuentes · 17問 · 2年前

    Introduction.

    Introduction.

    17問 • 2年前
    Quinn Karylle Fuentes

    Introduction of biochemistry

    Introduction of biochemistry

    Quinn Karylle Fuentes · 76問 · 2年前

    Introduction of biochemistry

    Introduction of biochemistry

    76問 • 2年前
    Quinn Karylle Fuentes

    Intro medicanal chemistry.

    Intro medicanal chemistry.

    Quinn Karylle Fuentes · 56問 · 2年前

    Intro medicanal chemistry.

    Intro medicanal chemistry.

    56問 • 2年前
    Quinn Karylle Fuentes

    Carbohydrates

    Carbohydrates

    Quinn Karylle Fuentes · 75問 · 2年前

    Carbohydrates

    Carbohydrates

    75問 • 2年前
    Quinn Karylle Fuentes

    Carbohydrates 1.1

    Carbohydrates 1.1

    Quinn Karylle Fuentes · 31問 · 2年前

    Carbohydrates 1.1

    Carbohydrates 1.1

    31問 • 2年前
    Quinn Karylle Fuentes

    Detect and quality variation.

    Detect and quality variation.

    Quinn Karylle Fuentes · 56問 · 2年前

    Detect and quality variation.

    Detect and quality variation.

    56問 • 2年前
    Quinn Karylle Fuentes

    INTRODUCTION

    INTRODUCTION

    Quinn Karylle Fuentes · 98問 · 2年前

    INTRODUCTION

    INTRODUCTION

    98問 • 2年前
    Quinn Karylle Fuentes

    lab (1-2)

    lab (1-2)

    Quinn Karylle Fuentes · 15問 · 2年前

    lab (1-2)

    lab (1-2)

    15問 • 2年前
    Quinn Karylle Fuentes

    lab 1-2

    lab 1-2

    Quinn Karylle Fuentes · 14問 · 2年前

    lab 1-2

    lab 1-2

    14問 • 2年前
    Quinn Karylle Fuentes

    Pharmaceutical chemistry.

    Pharmaceutical chemistry.

    Quinn Karylle Fuentes · 45問 · 2年前

    Pharmaceutical chemistry.

    Pharmaceutical chemistry.

    45問 • 2年前
    Quinn Karylle Fuentes

    Pharmaceutical chemistry 1.1

    Pharmaceutical chemistry 1.1

    Quinn Karylle Fuentes · 35問 · 2年前

    Pharmaceutical chemistry 1.1

    Pharmaceutical chemistry 1.1

    35問 • 2年前
    Quinn Karylle Fuentes

    Unit 3.

    Unit 3.

    Quinn Karylle Fuentes · 39問 · 2年前

    Unit 3.

    Unit 3.

    39問 • 2年前
    Quinn Karylle Fuentes

    Histamin and kinins

    Histamin and kinins

    Quinn Karylle Fuentes · 70問 · 2年前

    Histamin and kinins

    Histamin and kinins

    70問 • 2年前
    Quinn Karylle Fuentes

    PUD.

    PUD.

    Quinn Karylle Fuentes · 45問 · 2年前

    PUD.

    PUD.

    45問 • 2年前
    Quinn Karylle Fuentes

    ..

    ..

    Quinn Karylle Fuentes · 61問 · 2年前

    ..

    ..

    61問 • 2年前
    Quinn Karylle Fuentes

    Lipids.

    Lipids.

    Quinn Karylle Fuentes · 67問 · 2年前

    Lipids.

    Lipids.

    67問 • 2年前
    Quinn Karylle Fuentes

    lipids.

    lipids.

    Quinn Karylle Fuentes · 71問 · 2年前

    lipids.

    lipids.

    71問 • 2年前
    Quinn Karylle Fuentes

    LAB ✨

    LAB ✨

    Quinn Karylle Fuentes · 93問 · 2年前

    LAB ✨

    LAB ✨

    93問 • 2年前
    Quinn Karylle Fuentes

    Drug discovery.

    Drug discovery.

    Quinn Karylle Fuentes · 87問 · 2年前

    Drug discovery.

    Drug discovery.

    87問 • 2年前
    Quinn Karylle Fuentes

    disease of lipids.

    disease of lipids.

    Quinn Karylle Fuentes · 13問 · 2年前

    disease of lipids.

    disease of lipids.

    13問 • 2年前
    Quinn Karylle Fuentes

    Intro (identify structure)

    Intro (identify structure)

    Quinn Karylle Fuentes · 57問 · 2年前

    Intro (identify structure)

    Intro (identify structure)

    57問 • 2年前
    Quinn Karylle Fuentes

    Carbohydrates

    Carbohydrates

    Quinn Karylle Fuentes · 98問 · 2年前

    Carbohydrates

    Carbohydrates

    98問 • 2年前
    Quinn Karylle Fuentes

    Dynamic.

    Dynamic.

    Quinn Karylle Fuentes · 96問 · 2年前

    Dynamic.

    Dynamic.

    96問 • 2年前
    Quinn Karylle Fuentes

    Unit 1

    Unit 1

    Quinn Karylle Fuentes · 32問 · 2年前

    Unit 1

    Unit 1

    32問 • 2年前
    Quinn Karylle Fuentes

    問題一覧

  • 1

    transitions between energy levels may be generated by radiant energy if the molecules are first placed in a magnetic field.

    Nuclear magnetic resonance

  • 2

    investigate the properties of organic molecules, like sructure/ identity, and molecular configuration

    Nuclear magnetic resonance

  • 3

    an energy transfer is possible between the base energy to a higher energy leve

    Nuclear magnetic resonance

  • 4

    energy transfer takes place at a wavelength that corresponds to radio frequencies

    Nuclear magnetic resonance

  • 5

    The signal that matches this transfer is measured in many ways and processed in order to yield an NMR spectrum for the nucleus concerned. (T/F)

    True

  • 6

    the plot of radio frequency applied against absorption

    NMR Spectrum

  • 7

    signal in the spectrum

    Resonance

  • 8

    form of electromagnetic radiation to pump the excess alpha oriented nuclei into the beta state.

    Nuclear magnetic resonance

  • 9

    exploits the magnetic properties of certain atomic nuclei. ... Thus, in organic chemistry practice, NMR analysis is used to confirm the identity of a substance. (T/F)

    True

  • 10

    frequency of the signal expressed with reference to a standard Computed as the difference between the resonance frequency of the nucleus and a standard, relative to the standard.

    Chemical shift

  • 11

    as a fraction of the nominal resonance frequency or parts-per-million (ppm) are used.

    Chemical shift

  • 12

    a phenomenon that takes place due to the neighboring proton

    Spin-spin couple

  • 13

    peaks are split into multiplets which depend upon the groups on adjacent nuclei.

    Spin spin coupling

  • 14

    difference between the adjacent sub-peaks in a split signal

    J coupling

  • 15

    The basic instrumentation needed to measure NMR spectra includes (

    magnet with strong, stable homogenous field, radio receiver and detector, radiofrequency transmitter:, coil of wire, cell containing the sample

  • 16

    It is an instrumental method for identifying the chemical constitution of a substance by means of the separation of gaseous ions according to their differing mass and charge.

    Mass spectrometry.

  • 17

    generates multiple ions from the sample under investigation, it then separates them according to their specific mass-to-charge ratio (m/z), and then records the relative abundance of each ion type.

    Mass spectrometry

  • 18

    For producing gaseousionsfrom the substance being studied

    Ion source

  • 19

    For resolving the ionsinto their characteristicsmass components according to their mass-to-charge ratio.

    Analyzer

  • 20

    For detecting the ions and recording the relative abundance of each of the resolved ionic species.

    Detectors systems

  • 21

    Mass spectrometer always work with positive ions (T/F)

    True

  • 22

    The ions are then deflected by a magnetic field according to their masses. The lighter they are, the more they are deflected

    Deflected.

  • 23

    The ions are accelerated so that they all have the same kinetic energy

    Accelerated.

  • 24

    is a process in which a solution of mixture containing inert materials, drug principles and impurities is separated into its components while moving through a bed of fixed porous solid having different and reversible affinities for the substance being separate

    Chromatography

  • 25

    a fixed bed core of large surface area.

    Stationary phase

  • 26

    a fluid which moves through or over the surface of the stationary phase.

    Mobile phase

  • 27

    Whar are the 2 types of chromatography

    Stationary phase, Mobile phase

  • 28

    It brings about the separation of a mixture through a competitive process in which the molecules of the mobile phase compete with the analyte molecules for polar adsorption site on the adsorbent.

    Adsorption Chromatography

  • 29

    The chromatographic process is known as where the mobile phase is liquid.

    liquid-solid chromatography

  • 30

    The chromatographic process is known as when the mobile phase is a gas

    gas – solid chromatography

  • 31

    Chromatographic technique in which the mobile and stationary phases are liquids referred to as liquid-liquid chromatography (LLC)

    Partition Chromatography

  • 32

    Separation in partition elution chromatography is based upon

    Nernst’s law.

  • 33

    According to this law, when two practically immiscible solvents are in contact with each other and substance which is soluble in each is added, the substance distributes itself in such a way that at equilibrium and at a given temperature the ratio of the concentrations of the two solutions is constant.

    Nernst’s law.

  • 34

    it is the activity ratio rather than the concentration ratio which remains constant

    Nernst’s law.

  • 35

    the ratio of the distance travelled over the paper sheets by a given compound to the distance travelled by the front of the mobile phase, from the point of application of the test substances.

    Retardation Factor (Rf)

  • 36

    the ratio between the distances travelled by a given compound and a reference substance.

    Retardation Reference (Rr)

  • 37

    The materials used to pack column for use inion-exchange chromatography are either cationic or anionic exchange resins.

    Ion-Exchange Chromatography

  • 38

    These substances are insoluble in water and as the name implies, exchange cations or anions in solution in the mobile phase which come in contact with the active sites of exchange resins

    Ion-Exchange Chromatography

  • 39

    Contains either sulfonic acid (-SO3H) or carboxylic acid

    Cationic exchangers

  • 40

    Resin contain either quaternary ammonium or amino functional group in the Y position.

    Anionic exchange

  • 41

    stationary phase consists of a polymeric matrix onto the surface of which ionic functional groups, e.g. carboxylic acid or quaternary amines have been chemically bonded

    Ion exchange chromatography

  • 42

    As the mobile phase passes over this surface, ionic solutes are retained by forming electrostatic chemical bonds with the functional groups. The mobile phase used in ion exchange chromatography are always liquid.

    Ion exchange chromatography

  • 43

    This is also known as gel filtration or gel permeation chromatography, and maybe defined as a separation procedure in which differential migration of solute molecules is based on molecular size

    Molecular Exclusion Chromatography

  • 44

    Column material consists of a network-like structure of polymer material having pores of various sizes which exclude some molecules but permit the passage of other smaller molecules.

    Molecular Exclusion Chromatography

  • 45

    The simplest type of chromatographic column consists of a separation flask and a cylindrical glass tube constricted at one end.

    Column chromatography

  • 46

    The material placed in the column to absorb the drug is referred to as the .

    Adsorbent

  • 47

    Purified siliceous earth, activated alumina, silica gel and calcium carbonate are examples of adsorbents commonly used. (T/F)

    True

  • 48

    The adsorbent is uniformly and firmly packed into the tube so that the solvent called will pass through it.

    Mobile phase

  • 49

    The column adsorbent is treated with fresh portions of solvent referred to as ________ to bring about the separation of the components as each drug progress down the column at a characteristic rate in a chromatogram.

    Developer

  • 50

    used in highpressure liquid chromatography and gas chromatography

    Column chromatography

  • 51

    Ether is used as

    Eluant

  • 52

    When the separated compounds are colored or fluoresce under UV light the adsorbent column is forced, intact from the tube and the fractions are easily divided into segments with a knife.

    Column Chromatography

  • 53

    When the compounds are radioactive, their position on the column may be determined by the use of a

    Geiger-Muller counter.

  • 54

    Another procedure commonly used to develop chromatogram is known as

    Elution chromatography

  • 55

    The column is washed with suitable solvent referred to as

    eluants

  • 56

    until each compound is successively obtained in the effluent liquid known as the

    Eluate

  • 57

    The basic principle of separation in the partition chromatography is that of difference in partition coefficients of substances between two immiscible liquids.

    Paper-Partition Chromatography

  • 58

    One of which is a stationary phase supported on a solid adsorbent with the other mobile liquid phase flowing through it.

    Paper-Partition Chromatography

  • 59

    which is accomplished by allowing the mobile phase to flow downward on the paper strip.

    Descending Chromatography

  • 60

    An which the mobile phase is allowed to rise upward on the paper by capillary attraction

    Ascending Chromatography

  • 61

    in which the mobile phase moves out in concentric circles from the center of a circular piece of paper.

    Radial Chromatography,

  • 62

    When the compounds are colorless they may be visualized painting or spraying the extruded column with a

    color-forming agent.

  • 63

    It involves the spotting of a sampler of a mixture of components at one end of an adsorbent-coated glass plate or other suitable support followed by passage of solvent through the adsorbent for the purpose of separating components of the sample

    Thin-Layer Chromatography

  • 64

    are the most widely used adsorbents

    Silica Gel G, Alumina